These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 29870976)

  • 81. [pH-impedancemetry: clinical implications].
    Bertolini D; Roman S; Dumonceau JM
    Rev Med Suisse; 2008 Sep; 4(169):1873-4, 1876-8. PubMed ID: 18831408
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Patients with refractory reflux symptoms often do not have GERD.
    Herregods TV; Troelstra M; Weijenborg PW; Bredenoord AJ; Smout AJ
    Neurogastroenterol Motil; 2015 Sep; 27(9):1267-73. PubMed ID: 26088946
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study.
    Moretzsohn LD; Carvalho EB; Franco JD; Soares MP; Brito EM; Belarmino K; Coelho LG
    Can J Clin Pharmacol; 2009; 16(1):e264-72. PubMed ID: 19383986
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Weakly acidic refluxes have a major role in the pathogenesis of proton pump inhibitor-resistant reflux oesophagitis.
    Frazzoni M; Conigliaro R; Melotti G
    Aliment Pharmacol Ther; 2011 Mar; 33(5):601-6. PubMed ID: 21198705
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance can link PPI-responsive heartburn to reflux better than acid exposure time.
    Frazzoni L; Frazzoni M; de Bortoli N; Tolone S; Furnari M; Martinucci I; Bertani H; Marchi S; Conigliaro R; Fuccio L; Savarino V; Savarino E
    Neurogastroenterol Motil; 2017 Nov; 29(11):. PubMed ID: 28543861
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Functional heartburn patients demonstrate traits of functional bowel disorder but lack a uniform increase of chemoreceptor sensitivity to acid.
    Shapiro M; Green C; Bautista JM; Peru RL; Malagon IB; Corvo M; Risner-Adler S; Beeler JN; Tuchinsky I; Fass R
    Am J Gastroenterol; 2006 May; 101(5):1084-91. PubMed ID: 16573776
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association.
    Aanen MC; Weusten BL; Numans ME; de Wit NJ; Samsom M; Smout AJ
    J Clin Gastroenterol; 2008; 42(5):441-7. PubMed ID: 18344896
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy.
    Savarino E; Zentilin P; Tutuian R; Pohl D; Casa DD; Frazzoni M; Cestari R; Savarino V
    Am J Gastroenterol; 2008 Nov; 103(11):2685-93. PubMed ID: 18775017
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Ineffective esophageal motility: clinical, manometric, and outcome characteristics in patients with and without abnormal esophageal acid exposure.
    Shetler KP; Bikhtii S; Triadafilopoulos G
    Dis Esophagus; 2017 Jun; 30(6):1-8. PubMed ID: 28475749
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
    Weigt J; Kandulski A; Büsch F; Malfertheiner P
    Dig Dis; 2009; 27(1):68-73. PubMed ID: 19439964
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Esophageal hypermotility: cause or effect?
    Crespin OM; Tatum RP; Yates RB; Sahin M; Coskun K; Martin AV; Wright A; Oelschlager BK; Pellegrini CA
    Dis Esophagus; 2016 Jul; 29(5):497-502. PubMed ID: 25893778
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux, or both?
    Tack J; Koek G; Demedts I; Sifrim D; Janssens J
    Am J Gastroenterol; 2004 Jun; 99(6):981-8. PubMed ID: 15180713
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Evaluation of Gastroesophageal Reflux by Combined Multichannel Intraluminal Impedance and pH Monitoring and Esophageal Motility Patterns in Children with Esophageal Atresia.
    Tong S; Mallitt KA; Krishnan U
    Eur J Pediatr Surg; 2016 Aug; 26(4):322-31. PubMed ID: 26445355
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Functional heartburn: definition and management strategies.
    Zerbib F; Bruley des Varannes S; Simon M; Galmiche JP
    Curr Gastroenterol Rep; 2012 Jun; 14(3):181-8. PubMed ID: 22451252
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
    Schey R; Alla SP; Midani D; Parkman HP
    Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Disease progression in non-erosive reflux disease (NERD): impact of initial esophageal acid exposure.
    Chen CL; Liu TT; Yi CH
    Dis Esophagus; 2010 Nov; 23(8):613-7. PubMed ID: 20545977
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Efficacy of a potassium-competitive acid blocker for improving symptoms in patients with reflux esophagitis, non-erosive reflux disease, and functional dyspepsia.
    Asaoka D; Nagahara A; Hojo M; Matsumoto K; Ueyama H; Matsumoto K; Izumi K; Takeda T; Komori H; Akazawa Y; Shimada Y; Osada T; Watanabe S
    Biomed Rep; 2017 Feb; 6(2):175-180. PubMed ID: 28357069
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Addition of esophageal impedance monitoring to pH monitoring increases the yield of symptom association analysis in patients off PPI therapy.
    Bredenoord AJ; Weusten BL; Timmer R; Conchillo JM; Smout AJ
    Am J Gastroenterol; 2006 Mar; 101(3):453-9. PubMed ID: 16464226
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Frequency of functional esophageal disorders in patients with refractory reflux symptoms in Lima, Peru.
    Piza-Palacios L; Cárdenas-Oña M; Vásquez-Ojeda X; Alurralde C; Rosas E; Samalvides-Cuba F; Espinoza-Ríos J
    Rev Gastroenterol Peru; 2023; 43(3):242-250. PubMed ID: 37890849
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Long-term outcomes of patients with symptomatic gastroesophageal reflux disease treated with vonoprazan.
    Shinozaki S; Osawa H; Kobayashi Y; Sakamoto H; Hayashi Y; Miura Y; Kawarai Lefor A; Yamamoto H
    Scand J Gastroenterol; 2018 Aug; 53(8):897-904. PubMed ID: 30056768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.